Published on 11 May 2022 on Simply Wall St. via Yahoo Finance

When Will Precipio, Inc. (NASDAQ:PRPO) Breakeven?

We feel now is a pretty good time to analyse Precipio, Inc.'s (NASDAQ:PRPO) business as it appears the company may be on the cusp of a considerable accomplishment. Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. On 31 December 2021, the US$26m market-cap company posted a loss of US$8.5m for its most recent financial year. Many investors are wondering about the rate at which Precipio will turn a profit, with the big question being “when will the company breakeven?” We've put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate.

See our latest analysis for Precipio

Expectations from some of the American Healthcare analysts is that Precipio is on the verge of breakeven. They expect the company to post a final loss in 2022, before turning a profit of US$123k in 2023. The company is therefore projected to breakeven just over a year from now. In order to meet this breakeven date, we calculated the rate at which the company must grow year-on-year. It turns out an average annual growth rate of 68% is expected, which signals high confidence from analysts. Should the business grow at a slower rate, it will become profitable at a later date than expected.